ASCO GU 2024: Dose-Escalated Radiotherapy Plus Long-Term Androgen Deprivation Therapy Safe, Effective for Patients With High-Risk Prostate Cancer
Patients saw significant improvements in biochemical progression-free survival
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.